Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionel Mignion

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|July 10, 2018
2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neckLionel Mignion, Sandra Schmitz, Nicolas Michoux, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapyOussama Karroum, Julie Kengen, Pierre Danhier, et al.
Journal of Cellular and Molecular Medicine|July 19, 2020
Obesity and triple-negative-breast-cancer: Is apelin a new key target?Florian Gourgue, Lionel Mignion, Matthias Van Hul, et al.
Magnetic Resonance in Medicine|October 2, 2012
Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenationBénédicte F Jordan, Julie Magat, Florence Colliez, et al.
Nature Cancer|December 15, 2022
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancerFederica Cappellesso, Marie-Pauline Orban, Niranjan Shirgaonkar, et al.
Nature Communications|January 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinomaValentin Van den Bossche, Julie Vignau, Engy Vigneron, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|July 10, 2018
2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neckLionel Mignion, Sandra Schmitz, Nicolas Michoux, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapyOussama Karroum, Julie Kengen, Pierre Danhier, et al.
Journal of Cellular and Molecular Medicine|July 19, 2020
Obesity and triple-negative-breast-cancer: Is apelin a new key target?Florian Gourgue, Lionel Mignion, Matthias Van Hul, et al.
Magnetic Resonance in Medicine|October 2, 2012
Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenationBénédicte F Jordan, Julie Magat, Florence Colliez, et al.
Nature Cancer|December 15, 2022
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancerFederica Cappellesso, Marie-Pauline Orban, Niranjan Shirgaonkar, et al.
Nature Communications|January 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinomaValentin Van den Bossche, Julie Vignau, Engy Vigneron, et al.
Pageof 4